Nemak, S. A. B. de C. V.
Nemak, S. A. B. de C. V. (NMAKF) Financial Performance & Income Statement Overview
Explore the financials of Nemak, S. A. B. de C. V. (NMAKF), including yearly and quarterly data on income, cash flow, and balance sheets.
Nemak, S. A. B. de C. V. (NMAKF) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Nemak, S. A. B. de C. V. NMAKF financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.21B | $1.21B | $1.22B | $1.26B |
| Cost of Revenue | $1.08B | $1.09B | $1.07B | $1.10B |
| Gross Profit | $135.34M | $120.95M | $158.97M | $159.69M |
| Gross Profit Ratio | $0.11 | $0.10 | $0.13 | $0.13 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $81.06M | $85.62M | $86.55M | $90.02M |
| Operating Expenses | $85.75M | $160.41M | $86.36M | $90.02M |
| Total Costs & Expenses | $1.16B | $1.25B | $1.15B | $1.19B |
| Interest Income | $1.14M | $918000.00 | $975000.00 | $2.05M |
| Interest Expense | $28.09M | $46.29M | $32.25M | $42.52M |
| Depreciation & Amortization | $92.64M | $107.77M | $95.63M | $90.05M |
| EBITDA | $114.91M | $120.83M | $141.62M | $168.91M |
| EBITDA Ratio | $0.09 | $0.10 | $0.12 | $0.13 |
| Operating Income | $49.59M | -$39.46M | $72.61M | $56.82M |
| Operating Income Ratio | $0.04 | -$0.03 | $0.06 | $0.05 |
| Other Income/Expenses (Net) | -$55.40M | $4.44M | -$58.87M | -$20.48M |
| Income Before Tax | -$5.81M | -$35.02M | $13.74M | $36.34M |
| Income Before Tax Ratio | -$0.005 | -$0.03 | $0.01 | $0.03 |
| Income Tax Expense | $10.68M | $15.63M | $8.32M | -$8.92M |
| Net Income | -$16.49M | -$50.65M | $5.42M | $45.26M |
| Net Income Ratio | -$0.01 | -$0.04 | $0.004 | $0.04 |
| EPS | -$0.006 | -$0.02 | $0.002 | $0.01 |
| Diluted EPS | -$0.006 | -$0.02 | $0.002 | $0.01 |
| Weighted Avg Shares Outstanding | $2.94B | $2.94B | $3.03B | $3.03B |
| Weighted Avg Shares Outstanding (Diluted) | $2.94B | $2.94B | $3.03B | $3.03B |
The company's financials show resilient growth, with revenue advancing from $1.26B in Q2 2024 to $1.21B in Q1 2025. Gross profit remained healthy with margins at 11% in Q1 2025 compared to 13% in Q2 2024. Operating income hit $49.59M last quarter, sustaining a consistent 4% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $114.91M. Net income rose to -$16.49M, while earnings per share reached -$0.006. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan